Direct access to our audited laboratory pipelines, customized screening platforms, and preclinical validation facilities for multinational pharmaceutical and dietary supplement enterprises.
Overcoming the natural variability inherent in medicinal botany through precision chemical profiling, metabolic pathway identification, and reproducible scale-up paradigms.
Phytochemical therapeutics require rigorous chemistry, manufacturing, and control (CMC) dossiers. MedGence facilitates full IND-enabling analytical method establishment, toxicological profiling (GLP-compliant LD50, genotoxicity, sub-chronic toxicity), and Phase I–IV clinical study designs aligned with US FDA Botanical Drug Guidance and EMA HMPC herbal directives.
Moving beyond basic commodity powders, we engineer standardized phytochemical extracts featuring quantified Q-Markers (quality markers). We conduct in vitro enzymatic inhibition assays and placebo-controlled micro-human clinical trials to substantiate structural-function claims for North American and European nutraceutical brands.
High-end dermocosmetic applications demand high-affinity skin penetration, non-irritating solvent profiles, and proven anti-inflammatory, tyrosinase-inhibiting, or collagen-stimulating actions. Our cell-based in vitro models ensure every cosmetic active delivers statistically significant efficacy with zero cytotoxicity.
Global botanical procurement has evolved. Commodity trading is being displaced by deep phytochemical traceability, pesticide threshold management, and sustainable harvest governance.
Secondary metabolite concentrations within medicinal flora deviate drastically based on altitude, soil microbiota, rainfall, and harvest month. MedGence's potency evaluation studies quantify these deviations across 400+ single-herb types, locking in optimal harvest windows and geographic micro-climates to maintain consistent yield economics.
Exporting to the EU, USA, Japan, and South Korea requires compliance with pharmacopoeia chapters for heavy metals (lead, cadmium, arsenic, mercury), residual solvents, aflatoxins, PAH4, and multi-pesticide screens (>500 residues). Our analytical lab operates GC-MS/MS and LC-MS/MS suites configured specifically to exceed USP <561> and Ph. Eur. 2.8.13 mandates.
Lab-scale extraction often fails during pilot transfer due to compound denaturation, polymerization, or solvent channeling. We deploy low-temperature continuous countercurrent extraction, membrane concentration, and specialized macroporous adsorption resin columns to preserve heat-labile glycosides and volatile terpenes.
Fourteen years of sustained scientific investment, serving top-tier pharmaceutical conglomerates, university hospitals, and international innovators.
Years Dedicated to Natural Active R&D
Full-Time Phytochemists & Pharmacologists
Pharma Manufacturers & Hospitals Served
Classic TCM Formulas Modernized & Decoded
Innovative Natural Drug Formulations Created
Hospital Preparation Registrations Approved
Single-Herb Monograph Standards Established
Intellectual Property & Formula Confidentiality
From single assay execution to commercial contract manufacturing, our team eliminates information silos between laboratory discoveries and mass commercial execution.
Isolate and identify alkaloids, polysaccharides, flavonoids, and saponins. We screen natural plant populations using bioassay-guided fractionation to pinpoint optimal active compounds with confirmed affinity.
Systematic quantification of secondary metabolites collected across varied altitudes, seasons, and plant organs (roots, leaves, bark, seeds) to engineer predictable supply-chain models.
Development and ICH Q2(R1) validation of HPLC, HPTLC, GC, and multi-component fingerprint chromatography for comprehensive batch identity, purity, and stability quantification.
Pilot optimization of extraction kinetics, resin-purification ratios, solvent recovery, and vacuum freeze/spray drying to maximize active yield while reducing solvent footprints.
Engineering stable matrices for final formulations. We eliminate hygroscopicity, overcome insolubility, mask bitter herbal astringency, and prevent precipitation in oral liquids.
In-vivo safety determination including acute toxicity (LD50 testing), sub-chronic 90-day repeat dosing, Ames genotoxicity, and skin/mucosal sensitization assessments.
High-throughput screening across human and animal cell lines. Rapid validation of anti-oxidative, glucose-regulatory, anti-inflammatory, and apoptotic mechanisms prior to in-vivo testing.
Established animal disease models verifying systemic bioavailability, pharmacokinetic profiles (PK/PD), metabolic breakdown pathways, and dose-response relationship curves.
ICH-GCP compliant clinical study execution. Conducting human pharmacokinetic evaluations, micro-cohort dietary supplement efficacy trials, and Phase I–IV registrational drug studies.
Synergistic multi-compound formula design harnessing classical TCM theory and network pharmacology. Optimizing multi-herb interactions to maximize bio-potency and consumer safety.
Flexible cGMP contract supply of purified active components in high-viscosity paste, standardized extract powders, concentrated liquids, and supercritical volatile oils.
Commercial-scale OEM manufacturing of shelf-ready dosage forms including hard-shell capsules, softgels, precision-dosed oral liquids, functional effervescent tablets, and soluble granules.
International distribution of plant-derived active compounds demands localized regulatory agility. We assist global clients in satisfying regional authority benchmarks.
Complete documentation packages supporting 21 CFR Part 111 (Dietary Supplements) and 21 CFR Part 211 (Finished Pharmaceuticals). We prepare comprehensive New Dietary Ingredient (NDI) notifications, GRAS (Generally Recognized as Safe) scientific dossiers, and detailed raw material specifications matching United States Pharmacopeia (USP) monographs.
Rigorous chemical fingerprinting and heavy metal/PAH4 testing conforming to European Pharmacopoeia (Ph. Eur.) guidelines. Full technical data compilation for Traditional Herbal Medicinal Products (THMPD) under Directive 2004/24/EC, and safety verification according to European Food Safety Authority (EFSA) botanicals standards.
Customized compliance documentation for CFDA/NMPA hospital preparation standards, Japanese Ministry of Health, Labour and Welfare (MHLW) Kampo specifications, and Australian TGA listed medicine filings. Our bilingual regulatory liaison team handles complete translation, audit defense, and testing cross-verification.
Structured milestone transitions minimize scientific failure risk from raw material discovery to commercial shipping container loads.
High-density chemical profiling of plant taxa across regions and seasons to identify high-potency source accessions.
Deliverable: Phytochemical Discovery DossierStandardization of robust HPLC/GC/HPTLC assays, establishing precise retention time indexes and reference markers.
Deliverable: Validated QC Assay SOPBench-to-pilot transition defining critical process parameters (temperature, pressure, solvent ratio, cycle duration).
Deliverable: Pilot Batch Manufacturing RecordExecution of in vitro cell safety models and in vivo toxicity profiling (LD50, acute, sub-chronic, Ames testing).
Deliverable: Preclinical Safety SummaryHuman cohort safety/efficacy validation (dietary supplement human trials or Phase I–IV clinical programs).
Deliverable: Clinical Study Report (CSR)Full-scale commercial production in audited cleanrooms with strict batch-to-batch non-disclosure agreements.
Deliverable: Commercial CoA & BatchesMedGence is actively deploying machine learning algorithms trained on over 200,000 herbal research batches to model botanical molecular synergy, predict intestinal permeation rates, and forecast drug-herb interactions. In parallel, our ongoing pilot investments into enzymatic biotransformation and supercritical fluid fractionation are setting new benchmarks for solvent-free, carbon-neutral active ingredient processing.
Our contract research and extraction operations directly support leading pharmaceutical manufacturers, university hospitals, and scientific enterprises.
Direct technical clarifications for Chief Scientific Officers, R&D Directors, and Procurement Executives.
Engage our scientific team directly to initiate project scoping, analytical validation, or commercial supply quoting.
